Background: The longitudinal association between progressive temporal change in sexual (dys)function and mortality in older men. Methods: Community-dwelling men aged 70 years and older from the Concord Health and Ageing in Men Project were assessed at baseline (2005)(2006)(2007), n = 1,705), 2-years follow-up (n = 1,367), and 5-years follow-up (n = 958). Self-reported sexual function (erectile function and sexual activity) using standardized questions were analyzed by generalized estimating equations to examine the longitudinal prediction of mortality according to change in sexual function across three time-points. Results: Men reported to have erectile dysfunction increased from 64% to 80%, and to be sexually inactive increased from 56% to 59% over the course follow-up. In univariate analyses, erectile dysfunction (hazard ratio: 2.02, 95% confidence interval [CI]: 1.45-2.81) or having no sexual activity (hazard ratio: 2.31, 95% CI: 1.82-2.93) at baseline predicted increased mortality over the subsequent 7 years. Models adjusted for multivariate and major reproductive hormones had negligible impact on mortality prediction, but neither statistically significantly predicted mortality after adjusting for depression. Similarly, change in erectile dysfunction over time was associated with mortality over 7 years in univariate (odds ratio: 1.69, 95% CI: 1.34-2.14) and multivariate analysis, including hormones, but not after adjusting for depression (odds ratio: 1.24, 95% CI: 0.95-1.62). Change in sexual activity was associated with mortality over 7 years in univariate analysis (odds ratio: 2.37, 95% CI: 1.33-4.20) but not after adjusting for age (odds ratio: 1.45, 95% CI: 0.79-2.64). Conclusions: Our analyses suggest sexual dysfunction was not an independent risk factor of, but rather may be a biomarker for, all-cause mortality in older men.
with cardiovascular disease, depression (14) (15) (16) and ageing together with reproductive hormones (17) .
Some population-based cohort studies have reported that ED predicts all-cause mortality in men (18) (19) (20) (21) but only one prospective cohort study has reported sexual activity is an independent predictor of mortality in older men (22) . However, as these studies focused on prediction of mortality based on a single cross-sectional snapshot and not progressive temporal change in sexual function associated with mortality or with, depression or reproductive hormones as a potential covariables.
We have examined in this study the relationship between sexual (dys)function and all-cause mortality aiming to determine (a) whether ED or sexual activity predicts all-cause mortality, (b) the temporal longitudinal relationship between change in ED and change in sexual activity over time and all-cause mortality, and (c) the impact of depression and reproductive hormones as covariables.
Methods

Population
CHAMP is an epidemiological population-based cohort study of a wide range of health issues in 1,705 community-dwelling Australian men aged 70 years and over which has been described in detail elsewhere (23) . Briefly, CHAMP recruited men in a well-defined urban region surrounding Concord Hospital, Sydney, Australia. The sampling frame was the compulsory New South Wales Electoral Roll. The only exclusion criterion was living in a residential aged care facility.
Data Collection
Baseline data collected between January 2005 and June 2007 comprised a questionnaire and clinic visit in which physical performance and biological measures, medication inventory and neuropsychological testing were performed in a single clinic. Follow-up assessments were conducted after 2 years (n = 1,367, January 2007 to October 2009) and 5 years (n = 958, January 2012 to October 2013), using the same measures as at baseline. Height and weight were measured and body mass index was calculated as kg/m 2 
Measurements
Sexual function
Men completed in private a self-reported sexual health questionnaire with questions about ED and sexual activity which was put in sealed envelopes and not seen by clinic interviewers. Men (n = 484, 27%) declined to complete the sexual health questionnaire were not included in this study. A standard, validated question for ED was used, "How often are you able to get and keep an erection that is firm enough for satisfactory sexual activity?" (24) . Erectile function was dichotomized into groups (none or minimal and moderate and complete) (24) . Sexual activity was based on the question, "How many times over the LAST MONTH have you had sexual activity (including intercourse and masturbation) reaching ejaculation?" Responses were dichotomized into no sexual activity (median) and 1 or more times in the last month.
Mortality
All men were phoned at four monthly intervals from the baseline clinic assessment, which enabled regular updating of survival data.
Men who were not contactable by phone were sent letters at four monthly intervals. If men withdrew from the study but agreed to passive follow up, the New South Wales Registry of Births, Deaths and Marriages was contacted to ascertain death status. Mortality follow-up ended on the date of death, date of withdrawal or February 17, 2015. Follow-up until the date of analysis was for a median of 6.9 years (range 4.0 days to 8.4 years) during which time there were 581 deaths and 56 men lost to follow-up.
Sociodemographic, economic and lifestyle measures
Sociodemographic variables included age, marital status (married vs not married), country of birth (Australian-born, overseas-born from an English-speaking country, and overseas-born from a non-English speaking country), income (government pension only vs other sources of income), smoking status (never smoker, ex-smoker, current smoker), alcohol intake (current nondrinkers, lifelong abstainers and ex-drinkers) with frequency and quantity of alcohol intake among those consuming at least 12 drinks in the past year which was categorized as safe (1-21 drinks per week) versus harmful drinkers (>21 drinks per week) (25) . Physical activity was measured using the Physical Activity Scale for the Elderly (PASE) scale (26) .
Health status
Data on 17 different medical conditions were obtained from the self-reported questionnaires in which participants reported whether a doctor or a health care provider had told them that they had as described previously (27) . Depressive symptoms were evaluated by the Geriatric Depression Scale, short form (GDS) (28) with five or more depressive symptoms considered as indicative of possible depression. Cardiovascular disease was defined by heart attack, myocardial infarction and stroke. Physical disability was defined as needing help with ≥1 activities on the modified Katz activities of daily living (ADL) scale (29) . Disability in instrumental ADLs (IADL) was defined as needing help with ≥1 activities included in the OARS IADL scale (30) .
Reproductive Hormone Measurement
Participants had an early morning fasting blood sample taken at all three time-points, with serum stored at −80°C until assay. Measurements of serum T, DHT, E2, and E1 were by liquid chromatography-tandem mass spectrometry (LC-MS/MS) as originally described (31) . Changes to improve assay performance by substituting ultrapressure for high pressure liquid chromatography with corresponding changes in extraction methodology were validated according to FDA criteria [see Supplementary Methods in (32) ]. The steroid measurements were calibrated against certified reference materials for T and DHT (National Measurement Institute, North Ryde, Australia), E2 (European Commission's Institute for Reference Materials and Measurements), and E1 (Cerilliant Corporation). The assays had between-run coefficients of variation at three levels (low, medium, high) of quality control (QC) specimens of 1.9%-4.5%, 3.8%-7.6%, 2.9%-13.6%, and 5.7%-8.7%, respectively, over 224 runs including all samples from the three waves of this study. Overlapping QC samples were routinely run at the start, middle and end of every run with each new QC control run multiple times for calibration before use. There was no evidence of assay drift in Levey-Jennings QC plots. Steroid profiles were measured in separate batches for the baseline, 2-year, and 5-year follow-up samples with all samples from one study period run together. The change to ultrapressure liquid chromatography was introduced between 2-and 5-year follow-up samplings after rigorous confirmation that it did not change accuracy or precision for any QC samples. The steroid assays had limits of quantification (defined by FDA/EMEA as lowest detectable measurement with coefficients of variation <20%) of 0.025 ng/mL (T), 0.10 ng/mL (DHT), 5 pg/mL (E2), and 3 pg/mL (E1). Serum SHBG was measured by automated immunoassays (Roche Diagnostics Australia, Dee Why, Australia) subject to ongoing external QC program calibration with between-assay coefficients of variation for 2 levels of QC specimens in each run of 2.0%-2.8% for SHBG.
Statistical Analyses
Analysis was carried out using STATA v12 (Stata Corp., College Station, TX). Descriptive characteristics were expressed as means (SD) and percentages. Differences in characteristics between participants in the total sample, survivors and deceased were compared using the two-sided t-test or chi-squared test. Univariate Cox regressions were conducted initially to determine the unadjusted hazard ratios (HRs) for mortality with each of the study measures. Subsequently Cox regression analysis was repeated with these variables, adjusting by baseline age and then by other covariables or risk factors. Variables that had a p < .1 in univariate analyses were then included in a stepwise Cox proportional hazards model. Backward stepwise elimination was used to eliminate nonsignificant variables to derive a final multivariate model. In the final model, the proportional hazards assumption was assessed through use of a time-dependent covariate and analysis of Schoenfeld residuals for each variable.
To study the longitudinal prediction between change in sexual activity and ED across three time-points with mortality, we used generalized estimating equation analyses (33) . Generalized estimating equation takes into account the time-varying nature of both the outcome and the exposure. Models were initially unadjusted, then age adjusted and then further adjusted by a priori covariables or risk factors at all three time-points including sociodemographic, lifestyle factors, health conditions and measures of clinical significance (Tables 3 and 5) .
Ethics Approval and Informed Consent
All participants gave written informed consent. The study was approved by the Sydney South West Area Health Service Human Research Ethics Committee, Concord Repatriation General Hospital, Sydney, Australia.
Results
The baseline characteristics of the study population with detailed characteristics according to survival status are shown in Table 1 with descriptive characteristics of the study population who did not complete the baseline sexual health questionnaire according to survival status in Supplementary Table 1 . There were significant differences in most baseline measures between the men who died during followup and those who survived, except for diabetes (see Table 1 ). The proportion of men self-reported to have ED was 64% at baseline, 67% at 2-year and 80% at 5-year follow-up. Furthermore, the proportion of men to be sexually inactive was 56% at a baseline and 59% at both 2-year and 5-year follow-up (data not shown).
Erectile Dysfunction
The associations of baseline ED with all-cause mortality are shown in Table 2 . Univariate analyses showed that men with ED had a significantly increased risk of mortality over 7 years with a HR of 2.02 (95% confidence interval [CI]: 1.45-2.81) compared to men with no ED (Table 2 ).
The strong univariate prediction of mortality over 7 years by baseline ED remained after adjustment by age (HR: 1.41, 95% CI: 1.01-1.98), and also by adjustment for age, income, body mass index, marital status, smoking status, alcohol consumption, diabetes, number of comorbidities, ADL disability, and cardiovascular disease (HR: 1.40, 95% CI: 1.01-2.02). With further adjustment for hormones (T, DHT, E2, E1, and SHBG), the magnitude of prediction (HR: 1.43, 95% CI: 0.99-2.07) remained very similar but with borderline nonsignificance. With further adjustment for depressive symptoms, ED no longer statistically significantly predicted mortality (HR: 1.34, 95% CI: 0.93-1.94). Depression was the only covariable which on adjustment produced more than minimal attenuation of the observed HR for ED in the multivariate prediction model.
The longitudinal prediction of all-cause mortality by change in ED status over the period spanning baseline, 2-year and 5-year follow-up are shown in Table 3 . Univariate analyses showed that men with ED over time had increased risk of mortality (HR: 1.69, 95% CI: 1.34-2.14) when compared to men who have no ED over time (Table 3) . Similarly, the change in ED over time remained statistically significant in predicting mortality in multivariate-adjusted model, including reproductive hormones (HR: 1.30, 95% CI: 1.00-1.69). However, with further adjustment for depression, change in ED no longer statistically significantly predicted mortality (HR: 1.24, 95% CI: 0.95-1.62).
Sexual Activity
Men who were sexually active in the month prior to baseline had a statistically significantly (p < .0001) higher survival rate than men with no sexual activity (Figure 1) .
The associations of sexual activity with all-cause mortality are shown in Table 4 . Univariate analyses showed that men with no sexual activity at baseline had a significantly increased risk of mortality over the subsequent 7 years (HR: 2.31, 95% CI: 1.82-2.93) when compared to men who had sexual activity at least once in the previous month (Table 4) . The association between sexual activity in the month preceding baseline and mortality remained strong after adjustment by age (HR: 1.50, 95% CI: 1.16-1.92) or with multivariate adjustment, including major reproductive hormones (HR: 1.40, 95% CI: 1.07-1.72). However, the statistically significant association was no longer present after further adjustment for depression (HR: 1.22, 95% CI: 0.94-1.61).
The longitudinal prediction of all-cause mortality by change in sexual activity over the period spanning baseline, 2-year and 5-year follow-up are shown in Table 5 . Univariate analyses showed that men with no sexual activity over time had increased risk of mortality (HR: 2.37, 95% CI: 1.33-4.20) when compared to men who were sexually active over time (Table 5) .
In contrast, the univariate prediction of mortality by changes in sexual activity over time was no longer significant when adjusted for age (odds ratio: 1.45, 95% CI: 0.79-2.64). The odds ratio after adjusting for multiple variables (odds ratio: 1.47, 95% CI: 0.81-2.71) was very similar to the age-adjusted model.
Discusssion
This study is the first longitudinal examination of the associations between changes in sexual function and all-cause mortality in older men. Men with no sexual activity at baseline were at greater risk of dying in the next 7 years than men who had at least one episode of sexual activity during the previous month. However, when examining changes in sexual activity across three time points over 7-years as a predictor of all-cause mortality, the strong association was attenuated by ageing. This suggests that a decline in sexual activity may represent a biomarker of health and in this context, a surrogate for advancing age or age-related factors.
Changes in ED in men remained a strong predictor of all-cause mortality when taking various potential covariables into consideration such as cardiovascular disease, diabetes, socioeconomic status, demographic, lifestyle factors, and reproductive hormones. These findings confirm previous reports with follow-up periods of 3-15 years Note: ADL = activities of daily living; ED = erectile dysfunction; GDS = Geriatric Depression Scale; PASE = Physical Activity Scale for the Elderly; SA = sexual activity. (18) (19) (20) (21) . However, in our study when adjusting for depressive symptoms, the association observed was no longer statistically significant, albeit not substantial change in point estimate. Nevertheless, this suggests that depressive symptoms may be an intermediate mediator in the relationship between ED and mortality. Similarly, low sexual activity at baseline strongly predicted mortality but this was attenuated when adjusting for depressive symptoms. Corollary evidence from systematic reviews and meta-analyses highlights a bidirectional association between depression and sexual dysfunction (34) . Furthermore, depressive symptoms may be an independent risk factor for mortality in older men (14) (15) (16) . Depressive symptoms therefore may possibly be on the causal pathway from sexual dysfunction to mortality in older men. However whether they are cause or effect in relationship to sexual dysfunction cannot be answered by this analysis A large prospective Taiwanese cohort study is to our knowledge the only previous study to have examined the longitudinal association between sexual activity and mortality (22) . The present study confirms their finding that men with no sexual activity at baseline had an increased risk of all-cause mortality. We also investigated whether changes in sexual activity over time is a predictor of increased risk of mortality and found no association after adjusting for age. Rather, the decline in sexual function observed in older men may be more directly attributable to ageing or represent a surrogate for age-related factors.
To date, the relationship between sexual dysfunction and mortality, through its association with cardiovascular disease, has received substantial attention. It is known that both ED and cardiovascular disease share similar pathophysiological mechanisms such as arterial occlusion, endothelial dysfunction and systematic inflammation (8) (9) (10) and progressive occlusive disease might manifest earlier in the smaller penile blood vessels compared with larger vessels (35, 36) . Therefore, the relationship between ED and mortality may be attributed ED as a sentinel feature for cardiovascular disease and/or as ED leading to depression; however, the precise relationships between these factors remain to be further elucidate from future studies.
We also examined whether male reproductive hormones may also explain the relationship between sexual function and mortality. Furthermore, both all-cause and cardiovascular disease mortality are significantly associated with low serum T in men in some, but not all, previous population-based epidemiological studies (17). However, our analyses did not show any further major differences in the results after adjusting major serum reproductive hormone levels. The present study suggests that sexual (dys)function should be considered as a biomarker of general health as well as a sentinel of cardiovascular disease. Furthermore our findings reinforces our previous interpretation that reproductive hormones including androgens (T, DHT) or estrogens (E2, E1) are unlikely to play a role in the reduced sexual function studied (37) . In any case, based on the present findings, it is unlikely that interventions to enhance diminished sexual function whether by treatment with phosphodiesterase type 5 inhibitors or testosterone can improve life expectancy. Furthermore, the available placebo-controlled studies suggest that testosterone is not effective at enhancing sexual function among older men without reproductive system pathology (38) (39) (40) . Nor does it further boost sexual function beyond the effects of sildenafil (41) .
Strengths of our study include the use of longitudinal data to provide a temporal framework to extend previous cross-sectional data to examine the contemporaneous associations between changes in sexual function and mortality. Another strength is that the CHAMP study includes a large and representative group of older community-dwelling Australian men, as shown by the similarity of sociodemographic and health characteristics compared to the nationally representative MATeS study (42) .
However, our study has some limitations. The CHAMP study had a baseline participation rate of approximately 50%, which is typical of longitudinal study in men of this age (43, 44) . Longitudinal studies are also subject to attrition (including deaths and loss at follow-up), a potential source of nonparticipation bias (45) . As our study was limited to community-dwelling men, it is likely that the frailest men in the community may not have participated. Diurnal variation and seasonal variation in hormone concentrations could also have influenced our results (46) . However, we have obtained a single morning fasting blood sample to minimize any possible variations.
This study suggests that there is no specific temporal relationship between changes in sexual activity over time with mortality independent of ageing, and that depression, but not reproductive hormones, may explain the relationship observed between ED and all-cause mortality in older men. Sexual dysfunction was not an independent risk factor of, but rather may be a biomarker for, allcause mortality in older men. Nevertheless, further studies are warranted to evaluate and justify our findings.
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